Profile	GDS4890 / 238700_at
Title	Systemic lupus erythematosus patients and yellow fever vaccine-immunized healthy donors: CD16+ monocytes
Organism	Homo sapiens

Graph caption help

Sample	Title	Value	Rank
GSM1256968	SLE-patients; Group 3: CD16pos, resident monocytes; active SLE 1	33.11	64
GSM1256969	SLE-patients; Group 3: CD16pos, resident monocytes; active SLE 2	33.6855	65
GSM1256970	SLE-patients; Group 3: CD16pos, resident monocytes; active SLE 3	45.6506	68
GSM1256971	SLE-patients; Group 3: CD16pos, resident monocytes; active SLE 4	42.173	67
GSM1256988	Yellow fever vaccinated NDs; Group 8: CD16pos, resident monocytes; ND 55 before YFV	56.8477	71
GSM1256991	Yellow fever vaccinated NDs; Group 9: CD16pos, resident monocytes; ND 55 seven days after YFV	55.4622	71
GSM1256989	Yellow fever vaccinated NDs; Group 8: CD16pos, resident monocytes; ND 56 before YFV	39.269	65
GSM1256992	Yellow fever vaccinated NDs; Group 9: CD16pos, resident monocytes; ND 56 seven days after YFV	62.582	72
GSM1256990	Yellow fever vaccinated NDs; Group 8: CD16pos, resident monocytes; ND 57 before YFV	42.252	67
GSM1256993	Yellow fever vaccinated NDs; Group 9: CD16pos, resident monocytes; ND 57 seven days after YFV	55.1992	71